Oliver Kayser: Technical Biochemistry, Kartoniert / Broschiert
Technical Biochemistry
- The Biochemistry and Industrial Use of Natural Products
(soweit verfügbar beim Lieferanten)
- Verlag:
- Springer, 05/2025
- Einband:
- Kartoniert / Broschiert
- Sprache:
- Englisch
- ISBN-13:
- 9783658471200
- Artikelnummer:
- 12179471
- Umfang:
- 288 Seiten
- Gewicht:
- 546 g
- Maße:
- 240 x 168 mm
- Stärke:
- 15 mm
- Erscheinungstermin:
- 15.5.2025
- Hinweis
-
Achtung: Artikel ist nicht in deutscher Sprache!
Klappentext
This textbook of biochemistry has been completely revised and expanded for its second edition. Biotechnologists and bioprocess engineers will find precise information on modern issues in the fascinating and complex field of technical biochemistry, where technology and biology need not be a contradiction. The authors have attempted to write a textbook for students of bioengineering from the students' perspective. Unlike well-known and well-established textbooks in biology, biochemistry, and biotechnology, this book presents biological concepts and links them with technical and engineering problems. The aim of this textbook is to shed light on biochemical principles in natural product biosynthesis and explain their biotechnological and bioprocess engineering production pathways.
Content:
Application of biochemistry in medicine, pharmacy, and engineering
Photosynthesis - The chemistry of light
Carbohydrate metabolism - Sugars as energy carriers
Amino acids and peptides - Proteins as biocatalysts
Carbohydrates, lipids, and proteins - Building blocks for technical and pharmaceutical substances
Important biosyntheses of primary and secondary metabolism
Natural product biosynthesis - Biology and chemistry of secondary metabolites
Target Audience:
Students of bioprocess engineering, biotechnology, pharmacy, chemistry
Biologists, biotechnologists, process engineers, pharmacists, chemists with a focus on biotechnology
Biografie (Oliver Kayser)
Oliver Kayser received his PhD at the Free University Berlin in 1997 following his fellowship at the University of Gainesville, Florida, whereupon he entered the pharmaceutical biotechnology industry. He is currently a lecturer at the Department of Pharmaceutics, Biopharmacy and Biotechnology at the FU Berlin, working on new biotech drugs from natural sources and on the development of drug delivery carriers based on nanosuspension and solid lipid nanoparticle enterprise technologies.